273 related articles for article (PubMed ID: 33230612)
1. Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions.
Shi X; He L; Zhang SM; Luo J
Stem Cell Rev Rep; 2021 Jun; 17(3):862-877. PubMed ID: 33230612
[TBL] [Abstract][Full Text] [Related]
2. Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges.
Ji J; Xu H; Li C; Luo J
Tissue Eng Part B Rev; 2023 Aug; 29(4):441-455. PubMed ID: 36884294
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCs.
Luo J; Qin L; Zhao L; Gui L; Ellis MW; Huang Y; Kural MH; Clark JA; Ono S; Wang J; Yuan Y; Zhang SM; Cong X; Li G; Riaz M; Lopez C; Hotta A; Campbell S; Tellides G; Dardik A; Niklason LE; Qyang Y
Cell Stem Cell; 2020 Feb; 26(2):251-261.e8. PubMed ID: 31956039
[TBL] [Abstract][Full Text] [Related]
4. Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts.
Cong X; Zhang SM; Batty L; Luo J
Stem Cells Dev; 2019 Dec; 28(24):1581-1594. PubMed ID: 31663439
[TBL] [Abstract][Full Text] [Related]
5. Efficient Differentiation of Human Induced Pluripotent Stem Cells into Endothelial Cells under Xenogeneic-free Conditions for Vascular Tissue Engineering.
Luo J; Shi X; Lin Y; Yuan Y; Kural MH; Wang J; Ellis MW; Anderson CW; Zhang SM; Riaz M; Niklason LE; Qyang Y
Acta Biomater; 2021 Jan; 119():184-196. PubMed ID: 33166710
[TBL] [Abstract][Full Text] [Related]
6. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells.
Generali M; Casanova EA; Kehl D; Wanner D; Hoerstrup SP; Cinelli P; Weber B
Acta Biomater; 2019 Oct; 97():333-343. PubMed ID: 31344511
[TBL] [Abstract][Full Text] [Related]
7. Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering.
Luo J; Lin Y; Shi X; Li G; Kural MH; Anderson CW; Ellis MW; Riaz M; Tellides G; Niklason LE; Qyang Y
Acta Biomater; 2021 Jan; 119():155-168. PubMed ID: 33130306
[TBL] [Abstract][Full Text] [Related]
8. Methods for Differentiating hiPSCs into Vascular Smooth Muscle Cells.
Li ML; Luo J; Ellis MW; Riaz M; Ajaj Y; Qyang Y
Methods Mol Biol; 2022; 2375():21-34. PubMed ID: 34591296
[TBL] [Abstract][Full Text] [Related]
9. Tissue engineered small-diameter vascular grafts.
Schmedlen RH; Elbjeirami WM; Gobin AS; West JL
Clin Plast Surg; 2003 Oct; 30(4):507-17. PubMed ID: 14621299
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells.
Wang L; Hu J; Sorek CE; Chen EY; Ma PX; Yang B
Expert Opin Biol Ther; 2016; 16(3):317-30. PubMed ID: 26560995
[TBL] [Abstract][Full Text] [Related]
11. Human iPSCs Stretch to Improve Tissue-Engineered Vascular Grafts.
Abutaleb NO; Truskey GA
Cell Stem Cell; 2020 Feb; 26(2):136-137. PubMed ID: 32032523
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.
Hibino N; Duncan DR; Nalbandian A; Yi T; Qyang Y; Shinoka T; Breuer CK
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):696-703. PubMed ID: 22244569
[TBL] [Abstract][Full Text] [Related]
13. Current Progress in Vascular Engineering and Its Clinical Applications.
Jouda H; Larrea Murillo L; Wang T
Cells; 2022 Jan; 11(3):. PubMed ID: 35159302
[TBL] [Abstract][Full Text] [Related]
14. Review: Tissue Engineering of Small-Diameter Vascular Grafts and Their In Vivo Evaluation in Large Animals and Humans.
Fang S; Ellman DG; Andersen DC
Cells; 2021 Mar; 10(3):. PubMed ID: 33807009
[TBL] [Abstract][Full Text] [Related]
15.
Keshavarzian M; Meyer CA; Hayenga HN
Tissue Eng Part C Methods; 2019 Nov; 25(11):641-654. PubMed ID: 31392930
[TBL] [Abstract][Full Text] [Related]
16. Tissue-engineered vascular grafts created from human induced pluripotent stem cells.
Sundaram S; One J; Siewert J; Teodosescu S; Zhao L; Dimitrievska S; Qian H; Huang AH; Niklason L
Stem Cells Transl Med; 2014 Dec; 3(12):1535-43. PubMed ID: 25378654
[TBL] [Abstract][Full Text] [Related]
17. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.
Fukunishi T; Best CA; Sugiura T; Opfermann J; Ong CS; Shinoka T; Breuer CK; Krieger A; Johnson J; Hibino N
J Thorac Cardiovasc Surg; 2017 Apr; 153(4):924-932. PubMed ID: 27938900
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations.
Krawiec JT; Weinbaum JS; Liao HT; Ramaswamy AK; Pezzone DJ; Josowitz AD; D'Amore A; Rubin JP; Wagner WR; Vorp DA
Tissue Eng Part A; 2016 May; 22(9-10):765-75. PubMed ID: 27079751
[TBL] [Abstract][Full Text] [Related]
19. Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells.
Eoh JH; Shen N; Burke JA; Hinderer S; Xia Z; Schenke-Layland K; Gerecht S
Acta Biomater; 2017 Apr; 52():49-59. PubMed ID: 28163239
[TBL] [Abstract][Full Text] [Related]
20. Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.
Radke D; Jia W; Sharma D; Fena K; Wang G; Goldman J; Zhao F
Adv Healthc Mater; 2018 Aug; 7(15):e1701461. PubMed ID: 29732735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
